Shareholder Alert: The Ademi Firm investigates whether UniFirst Corporation is obtaining a Fair Price for its Public Shareholders

Core Viewpoint - Ademi LLP is investigating UniFirst Corporation for potential breaches of fiduciary duty and other legal violations related to its transaction with Universal Health Services, focusing on whether shareholders are receiving a fair price [1] Group 1: Transaction Details - UniFirst shareholders will receive $155.00 in cash and 0.7720 shares of Cintas stock for each share owned, based on Cintas' closing price of $200.77 on March 9, 2026 [1] - The total value of the transaction is approximately $5.5 billion [1] Group 2: Board Conduct and Shareholder Rights - The transaction agreement imposes significant penalties on UniFirst for accepting competing bids, which may limit shareholder options [1] - Ademi LLP is examining the actions of the UniFirst board of directors to determine if they are fulfilling their fiduciary duties to all shareholders [1]